A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

NCT07071519 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Risankizumab
DRUG: Risankizumab

Sponsor

AbbVie